Everolimus Drug Information
A healthcare provider may prescribe everolimus (Afinitor®, Zortress®) to treat certain types of kidney cancer, pancreatic cancer, and brain tumors. Low doses of this medicine are also approved to help prevent organ rejection in certain people who receive a kidney transplant. Everolimus comes as a tablet that is taken once or twice daily.
Everolimus works by blocking certain enzymes that are responsible for regulating cell function, including cell growth. By blocking these enzymes, everolimus can slow down the growth of cancer cells. It also works by weakening the immune system so that after a kidney transplant, your body does not reject the new kidney and attack it.
Although it may be an effective medication, not everyone can use this drug. Information on everolimus should be discussed with your healthcare provider before starting treatment to minimize risks and to help ensure safe treatment. For example, tell your healthcare provider if you have had hepatitis B, if you are taking any other medications, or if you are pregnant or breastfeeding.
(For more information on this drug, click Everolimus. This article offers a complete overview, including details on safety and effectiveness, dosing guidelines, available strengths, and more.)